摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-chlorobenzyl)-2-(1,4-dimethyl-3-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yloxy)acetamide | 1312945-87-1

中文名称
——
中文别名
——
英文名称
N-(2-chlorobenzyl)-2-(1,4-dimethyl-3-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yloxy)acetamide
英文别名
N-[(2-chlorophenyl)methyl]-2-(1,4-dimethyl-3-phenylpyrazolo[3,4-b]pyridin-6-yl)oxyacetamide
N-(2-chlorobenzyl)-2-(1,4-dimethyl-3-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yloxy)acetamide化学式
CAS
1312945-87-1
化学式
C23H21ClN4O2
mdl
——
分子量
420.898
InChiKey
DEGZIJNOWAUTFD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    30
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    69
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • [EN] DISUBSTITUTED HETEROARYL-FUSED PYRIDINES<br/>[FR] PYRIDINES ACCOLÉES À DI-SUBSTITUTION HÉTÉROARYLE
    申请人:NOVARTIS AG
    公开号:WO2011076744A1
    公开(公告)日:2011-06-30
    The invention relates to compound of the formula (I') in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    这项发明涉及公式(I')的化合物,其中取代基如规范中所定义;以自由形式或盐形式存在;其制备方法,其作为药物的用途以及包含它的药物。
  • DISUBSTITUTED HETEROARYL-FUSED PYRIDINES
    申请人:Babiger Sangamesh
    公开号:US20120258973A1
    公开(公告)日:2012-10-11
    The invention relates to compound of the formula (I′) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    这项发明涉及式(I′)的化合物,其中取代基如规范中所定义;以自由形式或盐形式存在;其制备,其作为药物的用途以及包含它的药物。
  • Preparation and utility of substituted amphetamines
    申请人:Gant G. Thomas
    公开号:US20080045588A1
    公开(公告)日:2008-02-21
    Provided herein are substituted amphetamines, processes of preparation and pharmaceutical compositions thereof. Also provided are methods of their use for the treatment and/or management of trauma associated with a terminal disease, a post-traumatic-stress-disorder, or a psychological disorder.
  • US8742106B2
    申请人:——
    公开号:US8742106B2
    公开(公告)日:2014-06-03
查看更多